HealthTech Women<Partner Event>: The Microbiome

Please register here: https://htwmicrobiome.eventbrite.com

Consumers and industry have a new target… the Human Microbiome! “The human microbiome, is the study of 100 trillion bacteria that live in our bodies – that’s ten germs for every human cell. This mix of good and bad bacteria have been linked to everything from infectious diseases like clostridium difficile to obesity and even mental health.” Johnson and Johnson recently formed a partnership with Whole Biome.. which shifted this arena from R&D projects into real targets for pharmaceuticals and business opportunities alike.
Novel companies are sprouting up in this space. Specifically, they are creating therapies that alter the microbiome for human health or help better gain insights into why patients response better to certain therapies than others.
Peter DiLaura, CEO of Second Genome says that “We now have a capacity we never had before to interrogate and understand this really complex population of bacteria and how this bacteria interact with the host — the human biology,” Come join HealthTech Women on April 21st to experience and learn about this shift from science to reality! Watch the TED talk here on your microbiome by Rob Knight. Additional Resources:
The Microbiome: Brave New World for Health Care — and Biotech
http://www.fastcompany.com/3039891/gut-check

Agenda:

6:00-6:30pm: Networking + Light Appetizers
6:40-7:45pm: Keynote Speakers
Colleen Cutcliffe, Ph.D, CEO and Founder, Whole Biome
Tanya Yatsunenko, Ph.D Scientist, Second Genome
8:00-8:30pm: Q & A Interactive Discussion
8:30-9:15pm: Consumer Product Demos + Networking + Healthy Desserts
Demo Companies:
uBiome, AOBiome, and others! Keynote Speakers:
Colleen Cutcliffe, Ph.D, CEO and Founder, Whole Biome
3f59012-2.jpg
Colleen Cutcliffe is a Biochemist and Molecular Biologist with 10 years of experience managing and directing fundamental biology research teams in the academic, pharmaceutical and biotech sectors. Prior to co-founding Whole Biome, Colleen served as the Senior Manager of Biology at Pacific Biosciences where she met and collaborated with her fellow co-founders, John and Jim. Before her role at Pacific Biosciences, Colleen served as a Scientist in the Parkinson's Disease discovery group at Elan Pharmaceuticals. Colleen completed her postdoctoral research under Elizabeth Perlman at Children's Memorial Hospital in Chicago, IL, her Ph.D in Biochemistry and Molecular Biology under Cecile Pickart at Johns Hopkins University and her B.A. in Biochemistry from Wellesley College.

2. Tanya Yatsunenko, Ph.D Sr. Scientist, Second Genome
   TanyaYatsunenko.jpg
   Tanya Yatsunenko is a scientist at Second Genome, a clinical stage biotechnology company in South San Francisco that aims to transform lives with medicines developed through innovative microbiome science. The company has developed a proprietary Microbiome Discovery Platform, and has programs in inflammation and metabolic disease.

Prior to her work at Second Genome, Tanya was a PhD student and a postdoctoral scientist in the laboratory of Jeffrey Gordon at Washington University in St Louis, where she discovered how gut microbiota contributes to childhood malnutrition, and how gut microbiota changes with age, diet and geographical location.
http://www.secondgenome.com/